PCG Capital
PCG Capital is a holdings company focused in real estate into sports and recreation, technology, and payment transaction processing.
1 past transactions
CytoAgents
Series A in 2023
CytoAgents is a clinical-stage biotechnology company focused on developing innovative pharmaceutical products for treating life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.